Recent meta-analyses have showed that leukoaraiosis may be associated with a 1.5- to 1.9-fold increase in risk for SICH after tPA treatment [11–13] and a 2-fold greater risk of a poor functional outcome after stroke [11]. This evidence concerns the gene PLAT and Stroke.